# A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK

> **NCT03696407** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 108 (actual)

## Conditions studied

- Advanced Renal Cell Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03696407
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-20
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696407, "A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03696407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*